BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 25348256)

  • 1. The association between race and treatment regret among men with recurrent prostate cancer.
    Mahal BA; Chen MH; Bennett CL; Kattan MW; Sartor O; Stein K; D'Amico AV; Nguyen PL
    Prostate Cancer Prostatic Dis; 2015 Mar; 18(1):38-42. PubMed ID: 25348256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular comorbidity and treatment regret in men with recurrent prostate cancer.
    Nguyen PL; Chen MH; Hoffman KE; Chen RC; Hu JC; Bennett CL; Kattan MW; Sartor O; Stein K; D'Amico AV
    BJU Int; 2012 Jul; 110(2):201-5. PubMed ID: 22085233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal regret after treatment for low- and intermediate-risk prostate cancer.
    Hurwitz LM; Cullen J; Kim DJ; Elsamanoudi S; Hudak J; Colston M; Travis J; Kuo HC; Rice KR; Porter CR; Rosner IL
    Cancer; 2017 Nov; 123(21):4252-4258. PubMed ID: 28678408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Race, Decisional Regret and Prostate Cancer Beliefs: Identifying Targets to Reduce Racial Disparities in Prostate Cancer.
    DeWitt-Foy ME; Gam K; Modlin C; Kim SP; Abouassaly R
    J Urol; 2021 Feb; 205(2):426-433. PubMed ID: 33226309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced penile size and treatment regret in men with recurrent prostate cancer after surgery, radiotherapy plus androgen deprivation, or radiotherapy alone.
    Parekh A; Chen MH; Hoffman KE; Choueiri TK; Hu JC; Bennett CL; Kattan MW; Sartor O; Stein K; Graham PL; D'Amico AV; Nguyen PL
    Urology; 2013 Jan; 81(1):130-4. PubMed ID: 23273077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Treatment Modality, Functional Outcomes, and Baseline Characteristics With Treatment-Related Regret Among Men With Localized Prostate Cancer.
    Wallis CJD; Zhao Z; Huang LC; Penson DF; Koyama T; Kaplan SH; Greenfield S; Luckenbaugh AN; Klaassen Z; Conwill R; Goodman M; Hamilton AS; Wu XC; Paddock LE; Stroup A; Cooperberg MR; Hashibe M; O'Neil BB; Hoffman KE; Barocas DA
    JAMA Oncol; 2022 Jan; 8(1):50-59. PubMed ID: 34792527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regret in men treated for localized prostate cancer.
    Hu JC; Kwan L; Saigal CS; Litwin MS
    J Urol; 2003 Jun; 169(6):2279-83. PubMed ID: 12771770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment Decision Regret Among Long-Term Survivors of Localized Prostate Cancer: Results From the Prostate Cancer Outcomes Study.
    Hoffman RM; Lo M; Clark JA; Albertsen PC; Barry MJ; Goodman M; Penson DF; Stanford JL; Stroup AM; Hamilton AS
    J Clin Oncol; 2017 Jul; 35(20):2306-2314. PubMed ID: 28493812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determinants of treatment regret in low-income, uninsured men with prostate cancer.
    Hu JC; Kwan L; Krupski TL; Anger JT; Maliski SL; Connor S; Litwin MS
    Urology; 2008 Dec; 72(6):1274-9. PubMed ID: 18313115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decisional regret after robotic-assisted laparoscopic prostatectomy is higher in African American men.
    Collingwood SA; McBride RB; Leapman M; Hobbs AR; Kwon YS; Stensland KD; Schwartz RM; Pollard ME; Samadi DB
    Urol Oncol; 2014 May; 32(4):419-25. PubMed ID: 24411791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regret and fear in prostate cancer: The relationship between treatment appraisals and fear of recurrence in prostate cancer survivors.
    Maguire R; Hanly P; Drummond FJ; Gavin A; Sharp L
    Psychooncology; 2017 Nov; 26(11):1825-1831. PubMed ID: 28124398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality of care received and patient-reported regret in prostate cancer: Analysis of a population-based prospective cohort.
    Holmes JA; Bensen JT; Mohler JL; Song L; Mishel MH; Chen RC
    Cancer; 2017 Jan; 123(1):138-143. PubMed ID: 27622730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Race and risk of metastases and survival after radical prostatectomy: Results from the SEARCH database.
    Freedland SJ; Vidal AC; Howard LE; Terris MK; Cooperberg MR; Amling CL; Kane CJ; Aronson WJ;
    Cancer; 2017 Nov; 123(21):4199-4206. PubMed ID: 28654204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring Value From the Patient's Perspective Between Modern Radiation Therapy Modalities for Localized Prostate Cancer.
    Shaverdian N; Verruttipong D; Wang PC; Kishan AU; Demanes DJ; McCloskey S; Kupelian P; Steinberg ML; King CR
    Int J Radiat Oncol Biol Phys; 2017 Mar; 97(3):516-525. PubMed ID: 28126301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment regret and quality of life following radical prostatectomy.
    Ratcliff CG; Cohen L; Pettaway CA; Parker PA
    Support Care Cancer; 2013 Dec; 21(12):3337-43. PubMed ID: 23907238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association Between Androgen Deprivation Therapy and Patient-reported Depression in Men With Recurrent Prostate Cancer.
    Thomas HR; Chen MH; D'Amico AV; Bennett CL; Kattan MW; Sartor O; Stein K; Nguyen PL
    Clin Genitourin Cancer; 2018 Aug; 16(4):313-317. PubMed ID: 29866496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Local Therapy Decisional Regret in Older Women With Breast Cancer: A Population-Based Study.
    Advani PG; Lei X; Swanick CW; Xu Y; Shen Y; Goodwin NA; Smith GL; Giordano SH; Hunt KK; Jagsi R; Smith BD
    Int J Radiat Oncol Biol Phys; 2019 Jun; 104(2):383-391. PubMed ID: 30716524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate specific antigen kinetics at tumor recurrence after radical prostatectomy do not suggest a worse disease prognosis in black men.
    Bissonette EA; Fulmer BR; Petroni GR; Moul JW; Theodorescu D
    J Urol; 2001 Oct; 166(4):1328-31; discussion 1331-2. PubMed ID: 11547067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncologic outcomes among Black and White men with grade group 4 or 5 (Gleason score 8-10) prostate cancer treated primarily by radical prostatectomy.
    Wilkins LJ; Tosoian JJ; Reichard CA; Sundi D; Ranasinghe W; Alam R; Schwen Z; Reddy C; Allaf M; Davis JW; Chapin BF; Ross AE; Klein EA; Nyame YA
    Cancer; 2021 May; 127(9):1425-1431. PubMed ID: 33721334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are biochemical recurrence outcomes similar after radical prostatectomy and radiation therapy? Analysis of prostate cancer-specific mortality by nomogram-predicted risks of biochemical recurrence.
    Lee BH; Kibel AS; Ciezki JP; Klein EA; Reddy CA; Yu C; Kattan MW; Stephenson AJ
    Eur Urol; 2015 Feb; 67(2):204-9. PubMed ID: 25294696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.